Moonshot logo

Download

INTISMERAN

The Cancer Vaccine

$0.00139

$0.00138 (56150.16%)Past day

About

Moderna announced positive Phase 3 trial results for their personalized mRNA cancer vaccine. This is the first successful Phase 3 trial for an mRNA-based cancer vaccine.

WebsiteTwitter
Market cap*
$1.37M
VolumePast 24h
$21.31M
Holders
8.52K
Circulating supply*
991.73M
Created
Aug 19, 2026

Recent trades

Live
  • bought $12.50$0.00142
  • bought $16.14$0.00145
  • bought $1.91$0.00142